Search results
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 5 months agoRoivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript February 13, 2024 Roivant...
Editas (EDIT) Stock Gains 23% in the Past 6 Months: Here's Why
Zacks via Yahoo Finance Canada· 6 months agoEditas (EDIT) shares have gained 23% in the past six months, driven by encouraging findings from the...
Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy
Zacks via Yahoo Finance Canada· 7 months agoVertex Pharmaceuticals Incorporated VRTX announced that the Committee for Medicinal Products for...
Editas (EDIT) Licenses Cas9 Tool to Vertex, Stock Up 6%
Zacks via Yahoo Finance Canada· 7 months agoEditas (EDIT) stock rises 6% on a non-exclusive agreement with Vertex Pharmaceuticals to license its...
Kansas Citians with sickle cell disease may benefit from new FDA-approved treatments
Kansas City Star via Yahoo Canada News· 7 months agoSickle cell disease affects about 100,000 people in the United States, including an estimated 2,000...
BLUE, CRSP & VRTX Down Despite FDA Nod to SCD Therapies
Zacks via Yahoo Finance Canada· 7 months agoThe FDA approves two one-time gene therapies for treating sickle cell disease. One of them utilizes...
Q2 2023 AcelRx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 11 months agoParticipants Pamela Pierce Palmer; Co-Founder, Chief Medical Officer & Director; AcelRx Pharmaceuticals, Inc. Raffi Mark Asadorian; CFO; AcelRx Pharmaceuticals, Inc. Vincent J. Angotti; CEO ...
Geron says blood cancer drug succeeds in late-stage study, shares surge
Reuters via Yahoo Canada News· 2 years ago(Reuters) -Geron Corp said on Wednesday its experimental drug helped more patients with a...